What This FDA News Could Mean for AbbVie's Stock

What This FDA News Could Mean for AbbVie's Stock

Source: 
Motley Fool
News Tags: 
snippet: 
  • If approved, Rinvoq would gain access to nearly 200,000 potential patients.
  • The indication could generate $500 million in annual revenue for AbbVie.
  • AbbVie still looks like a great dividend growth stock for income investors.